Cytokinetics
Price & Volume
Stats
See more52W Range | $29.31-$61.48 |
Market Cap | $7.1B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $85.7M |
Revenue Growth (YoY) | 26,714.9% |
Gross Profit (12 Mos) | -$304.8M |
Diluted EPS | -$5.12 |
News
See moreYahoo Finance • yesterday
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI to Contact the Firm About their Rights in Filed Class Action Lawsuits
Yahoo Finance • 2 days ago
ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
Yahoo Finance • 3 days ago
Class Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join – Contact Levi & Korsinsky
Yahoo Finance • 3 days ago
Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated. Investors
About
CEO | Mr. Robert I. Blum |
CFO | Mr. Sung H. Lee |
Address | 350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 498 |
